Alopecia: Unapproved Treatments or Indications

    March 2000 in “ Clinics in Dermatology ”
    Marty E. Sawaya, Jerry Shapiro
    Studysummary This study developed a method using HPLC with UV-DAD and ESI-MS detection to identify prohibited substances like minoxidil and hormones in cosmetic products advertised online for hair loss and skin conditions.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on sciencedirect.com →
    Discuss this study in the Community →

    Research cited in this study 19

    1. Androgen Receptor Polymorphisms (CAG Repeat Lengths) in Androgenetic Alopecia, Hirsutism, and Acne Journal of Cutaneous Medicine and Surgery · 1998
    2. Hair Regrowth Dermatologic Clinics · 1998
    3. Comparison of Finasteride Versus Spironolactone in the Treatment of Idiopathic Hirsutism Fertility and Sterility · 1997
    4. Different Levels of 5α-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic Alopecia Journal of Investigative Dermatology · 1997
    5. Alopecia: The Search for Novel Agents Continues Expert Opinion on Therapeutic Patents · 1997
    6. Comparison of Flutamide and Spironolactone in the Treatment of Hirsutism: A Randomized Controlled Trial Fertility and Sterility · 1994
    7. Comparison of Finasteride (Proscar) and Serenoa Repens (Permixon) in the Inhibition of 5-Alpha Reductase in Healthy Male Volunteers European Urology · 1994
    8. A Comparative Study of a New Food Supplement, Viviscal, with Fish Extract for the Treatment of Hereditary Androgenic Alopecia in Young Males Journal of International Medical Research · 1992
    9. The Psychological Effects of Androgenetic Alopecia in Men Journal of The American Academy of Dermatology · 1992
    10. The Biological Effects of a Pulsed Electrostatic Field with Specific Reference to Hair Electrotrichogenesis International Journal of Dermatology · 1990
    11. Spironolactone Is an Effective and Well-Tolerated Systemic Antiandrogen Therapy for Hirsute Women The Journal of Clinical Endocrinology & Metabolism · 1989
    12. A Double-Blind, Placebo-Controlled Study With Kevis Lotion 1989
    13. The Management of Androgenetic Alopecia in Women Journal of Dermatological Treatment · 1989
    14. Delta 5-3 Beta-Hydroxysteroid Dehydrogenase Activity in Sebaceous Glands of Scalp in Male-Pattern Baldness Journal of Investigative Dermatology · 1988
    15. Side Effects of Spironolactone Therapy in the Hirsute Woman ˜The œJournal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism · 1988
    16. Pharmacology of Antiandrogens Journal of Steroid Biochemistry · 1986
    17. Oral Spironolactone Therapy for Female Patients with Acne, Hirsutism, or Androgenic Alopecia British Journal of Dermatology · 1985
    18. The Inheritance Of Common Baldness: To Be Or Not To Be? Journal of the American Academy of Dermatology · 1984
    19. Hair Loss During Lithium Treatment British Journal of Dermatology · 1982